CMV retinitis, newly diagnosed: RS-79070 trial in Atlanta, Austin, Boston, Durham, Houston, Irvine, Los Angeles (?), Miami, Montreal, New York (3 sites), San Diego, San Francisco (3 sites), Toronto, and Washington.
D000998:Antiviral Agents / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D011355:Prodrugs / Q000627:therapeutic use*
D000998:Antiviral Agents; D011355:Prodrugs; D015774:Ganciclovir